Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
6 hours ago
0
0
A new research paper titled "Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4" has been ...
17 hours ago
0
2
Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.
18 hours ago
0
1
In a stride toward enhancing cancer treatment, University of Birmingham researchers are using organ-on-a-chip technology to imitate the liver's environment and improve immunotherapy for liver cancer.
18 hours ago
0
0
A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) has unveiled a novel approach to stimulate muscle, by way of using brief and ...
18 hours ago
0
17
Behind the scenes, as tumors progress and gain resistance to treatment, a protein called YB-1 quietly gives directions. Now, researchers at Oregon Health & Science University have developed a first-of-its-kind drug that inhibits ...
19 hours ago
0
29
A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel ...
21 hours ago
0
92
When cells become tumor cells, their metabolism changes fundamentally. Researchers at the University of Basel and the University Hospital Basel have now demonstrated that this change leaves traces that could provide targets ...
21 hours ago
0
25
Madeleine Lehander from the Hematology Unit/HERM, at the Department of Medicine, Huddinge (MedH), is defending her thesis "Exploring T Cell Mediated Immunotherapy against Therapy Resistant Leukemic Stem Cells," on 24 May ...
May 20, 2024
0
6
We stand at the crossroads of medical innovation, where cutting-edge scientific discoveries intersect with the resilience of the human body, providing hope to families grappling with a diagnosis of pediatric leukemia.
May 20, 2024
0
0
